Nymox Pharmaceutical Signs New Sales And Marketing Agreement for Alzheimer's Test With Kyung Min Meditech Co. Ltd. In Korea
Published: Jun 14, 2006
HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--June 14, 2006--Nymox Pharmaceutical Corporation (NASDAQ:NYMX - News) announced today that it has entered into an agreement with Kyung Min Meditech Co., Ltd. for the marketing and sale of the Company's AlzheimAlert(TM) kit in the Korea Republic. AlzheimAlert(TM) provides physicians with a valuable tool for the diagnosis of Alzheimer's disease by measuring levels of a biomarker for Alzheimer's disease in patient urine samples. Kyung Min Meditech is a Korean medical device distributor headquartered in Seoul, Korea.